Investigation of response of patients with non－small cell lung cancer to docetaxel（plus ramucirumab) therapy in second-line treatment, Yutaka Takahara, Ryudai Abe, Sumito Nagae, Takuya Tanaka, Yoko Ishige, Ikuyo Shionoya, Kouichi Yamamura, Kazuaki Nishiki, Masafumi Nojiri, Ryo Kato, Shohei Shinomiya, Taku Oikawa, 14:3549-3555, Nov. 2023
Investigation of response factors for monotherapy with immnune checkpoint inhibitors in non-small cell lung cancer patients with PD-L1 expression <50%, Yutaka Takahara, Ryudai Abe, Nagae Sumito, Takuya Tanaka, Yoko Ishige, Ikuyo Shionoya, Kouichi Yamamura, Kazuaki Nishiki, Masafumi Nojiri, Ryo Kato, Shohei Shinomiya, Takua Oikawa, 27:2754-2760, Sep. 2023
A case of concurrent folicular lymphoma and lung cancer requiring differentiation from lymph node metastasis, Yutaka Takahara, Sumito Nagae, Aika Yamagata, Yoshihito Iijima, Akihiro Shioya, Sohsuke Yamada, Hidetaka Uramoto, Thorac Cancer, 2024:1-4, Feb. 2024
Disease control in patients with non-small cell lung cancer using pemetrexed: Investigating the best treatment strategy, Yutaka Takahara, Ryudai Abe, Nagae Sumito Takuya Tanaka, Yoko Ishige, Ikuyo Shionoya, Kouichi Yamamura, Kazuaki Nishiki, Masafumi Nojiri, Ryo Kato, Shohei Shinomiya, Taku Oikawa, Thorac Cancer, 2024:1-7, Mar. 2024
Investigation of the Efficacy of Epidermal Growth Factor Receptor（EGFR）－Tyrosine Kinase Inhibitor in Patients With Exon 21 L858R Point Mutation-Positive Non-small Cell Lung Cancer, Yutaka Takahara, Ryudai Abe, Sumito Nagae, Takuya Tanaka, Yoko Ishige, Ikuyo Shionoya, Kouichi Yamamura, Masafumi Nojiri, Masaharu Iguchi, Cureus, 16:e68411, Jun. 2024
Young-Onset, ROS1-Rearranged Adenocarcinoma of the Lung With Cardiac Tamponade: A Case Report, Masafumi Nojiri, Ryudai Abe, Sumito Nagae, Takuya Tanaka, Yutaka Takahara, Cureus, 16:e71777, Oct. 2024
Erythrocytosis as an indicator of diseasr progression of small cell lung cancer: A case report, Takuya Tanaka, Yutaka Takahara, Ryudai Abe, Sumito Nagae, Yoko Ishige, Ikuyo Shionoya, Kouichi Yamamura, Masafumi Nojiri, Masaharu Iguchi, Respiratory Medicine Case Report, 56:102240, May 2025
Treatment Response and Survival in Thyroid Transcription Factor-1 Negative Non-squamous Non-small Cell Lung Cancer, Yutaka Takahara, Ryudai Abe, Sumito Nagae, Takuya Tanaka, Yoko Ishige, Ikuyo Shionoya, Kouichi Yamamura, Masafumi Nojiri and Masaharu Iguchi, Cancer Diagnosis & Prognosis, 5:583-590, Jun. 2025
Prognostic Factors in Non-small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors, Yutaka Takahara, Ryudai Abe, Sumito Nagae, Takuya Tanaka, Yoko Ishige, Ikuyo Shionoya, Kouichi Yamamura, Masafumi Nojiri and Masaharu Iguchi, 45:5633-5644, Sep. 2025
Association Between Pretreatment White Blood Cell Count and Early Progression in Non-small Cell Lung Cancer, Yutaka Takahara, Ryudai Abe, Sumito Nagae, Takuya Tanaka, Yoko Ishige, Ikuyo Shionoya, Kouichi Yamamura, Masafumi Nojiri and Masaharu Iguchi, Cancer Diagnosis & Prognosis, 6:502-509, Feb. 2026
Pretreatment Tumor Growth Rate and Clinical Outcomes in Advabced Non-small Cell Lung Cancer, Yutaka Takahara, Ryudai Abe, Sumito Nagae, Takuya Tanaka, Yoko Ishige, Ikuyo Shionoya, Kouichi Yamamura, Masafumi Nojiri and Masaharu Iguchi, Anticancer Research, 46:3407-3415, Apr. 2026
